Study Targets Mutations Causing Breast Cancer Metastasis

Share this content:

the Cancer Therapy Advisor take:

Personalized medicine for patients with breast cancer may be a reality in the not-to-distant future. According to a study published on July 11 in the journal Science, six patients with breast cancer had their circulating cancer cells, which play an important role in metastasis, isolated.


Min Yu and colleagues at Massachusetts General Hospital and Harvard Medical School in Boston, MA, took these isolated breast cancer cells and expanded the number in their laboratory, which allowed them to identify mutations and evaluate drug susceptibility. This technique—once it is fine-tuned—could be applied to individual patients. Doctors may be able to isolate patients’ cancer cells in order to evaluate the progression of the disease, pre-test drugs, and develop personalized treatment plans.


In the study, the six patients with estrogen receptor –positive breast cancer had new mutations in the estrogen receptor gene ESR1, fibroblast growth factor receptor gene FGFR2, the PIK3CA gene, and others. The researchers tested individual anticancer drugs or combinations of different drugs that could potentially target cancer cells with these genetic mutations. Using this particular method, the researchers found that the drug ganetspib, or STA-9090, effectively killed cancer cells with the ESR1 mutation.

High-Fat Diet Ups Risk for Certain Breast Cancers
Study Targets Mutations Causing Breast Cancer Metastasis
For breast cancer patients, the era of personalized medicine may be just around the corner, thanks to recent advances by USC Stem Cell researcher Min Yu and scientists at Massachusetts General Hospital and Harvard Medical School. In a July 11 study in Science, Yu and her colleagues report how they isolated breast cancer cells circulating through the blood streams of six patients.
READ FULL ARTICLE From Medical Express

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs